135 related articles for article (PubMed ID: 7638082)
41. Prognostic value of immunohistochemical expression of the c-erbB-2 oncoprotein in metastasic prostate cancer.
Morote J; de Torres I; Caceres C; Vallejo C; Schwartz S; Reventos J
Int J Cancer; 1999 Aug; 84(4):421-5. PubMed ID: 10404097
[TBL] [Abstract][Full Text] [Related]
42. Estrogen induces apoptosis in a rat prostatic adenocarcinoma: association with an increased expression of TGF-beta 1 and its type-I and type-II receptors.
Landström M; Eklöv S; Colosetti P; Nilsson S; Damber JE; Bergh A; Funa K
Int J Cancer; 1996 Aug; 67(4):573-9. PubMed ID: 8759618
[TBL] [Abstract][Full Text] [Related]
43. An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumors.
Harper ME; Goddard L; Glynne-Jones E; Wilson DW; Price-Thomas M; Peeling WB; Griffiths K
Prostate; 1993; 23(1):9-23. PubMed ID: 7687782
[TBL] [Abstract][Full Text] [Related]
44. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens.
De Marzo AM; Knudsen B; Chan-Tack K; Epstein JI
Urology; 1999 Apr; 53(4):707-13. PubMed ID: 10197845
[TBL] [Abstract][Full Text] [Related]
45. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
[TBL] [Abstract][Full Text] [Related]
46. Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin.
Shen F; Long D; Yu T; Chen X; Liao Y; Wu Y; Lin X
Oncol Rep; 2017 Apr; 37(4):2481-2489. PubMed ID: 28259950
[TBL] [Abstract][Full Text] [Related]
47. In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate.
Bocker T; Bittinger A; Wieland W; Buettner R; Fauser G; Hofstaedter F; Rüschoff J
Mod Pathol; 1995 Apr; 8(3):226-31. PubMed ID: 7542384
[TBL] [Abstract][Full Text] [Related]
48. Isolation and characterization of propagable cell lines (HUNC) from the androgen-sensitive Dunning R3327H rat prostatic adenocarcinoma.
Presnell SC; Borchert KM; Glover WJ; Gregory CW; Mohler JL; Smith GJ
Carcinogenesis; 1998 Apr; 19(4):585-90. PubMed ID: 9600341
[TBL] [Abstract][Full Text] [Related]
49. Vascular endothelial zinc finger 1 is involved in the regulation of angiogenesis: possible contribution of stathmin/OP18 as a downstream target gene.
Miyashita H; Kanemura M; Yamazaki T; Abe M; Sato Y
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):878-84. PubMed ID: 15031128
[TBL] [Abstract][Full Text] [Related]
50. Serine 16 of oncoprotein 18 is a major cytosolic target for the Ca2+/calmodulin-dependent kinase-Gr.
Marklund U; Larsson N; Brattsand G; Osterman O; Chatila TA; Gullberg M
Eur J Biochem; 1994 Oct; 225(1):53-60. PubMed ID: 7925472
[TBL] [Abstract][Full Text] [Related]
51. Transforming properties of a Q18-->E mutation of the microtubule regulator Op18.
Misek DE; Chang CL; Kuick R; Hinderer R; Giordano TJ; Beer DG; Hanash SM
Cancer Cell; 2002 Sep; 2(3):217-28. PubMed ID: 12242154
[TBL] [Abstract][Full Text] [Related]
52. Mutations of oncoprotein 18/stathmin identify tubulin-directed regulatory activities distinct from tubulin association.
Larsson N; Segerman B; Gradin HM; Wandzioch E; Cassimeris L; Gullberg M
Mol Cell Biol; 1999 Mar; 19(3):2242-50. PubMed ID: 10022911
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.
Abrahamsson PA; Lilja H; Falkmer S; Wadström LB
Prostate; 1988; 12(1):39-46. PubMed ID: 2450341
[TBL] [Abstract][Full Text] [Related]
54. N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18).
Hailat N; Strahler J; Melhem R; Zhu XX; Brodeur G; Seeger RC; Reynolds CP; Hanash S
Oncogene; 1990 Nov; 5(11):1615-8. PubMed ID: 2267130
[TBL] [Abstract][Full Text] [Related]
55. Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics.
Marklund U; Larsson N; Gradin HM; Brattsand G; Gullberg M
EMBO J; 1996 Oct; 15(19):5290-8. PubMed ID: 8895574
[TBL] [Abstract][Full Text] [Related]
56. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
Fixemer T; Remberger K; Bonkhoff H
Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580
[TBL] [Abstract][Full Text] [Related]
57. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
Brändström A; Westin P; Bergh A; Cajander S; Damber JE
Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
[TBL] [Abstract][Full Text] [Related]
58. Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue.
Kitamura H; Torigoe T; Asanuma H; Hisasue SI; Suzuki K; Tsukamoto T; Satoh M; Sato N
Histopathology; 2006 Jan; 48(2):157-61. PubMed ID: 16405664
[TBL] [Abstract][Full Text] [Related]
59. Involvement of OP18 in cell proliferation.
Melhem RF; Strahler JR; Hailat N; Zhu XX; Hanash SM
Biochem Biophys Res Commun; 1991 Sep; 179(3):1649-55. PubMed ID: 1930203
[TBL] [Abstract][Full Text] [Related]
60. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis.
Quick CM; Gokden N; Sangoi AR; Brooks JD; McKenney JK
Hum Pathol; 2010 Aug; 41(8):1145-9. PubMed ID: 20413145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
